The Biden White House has brokered a deal between Johnson & Johnson and Merck that will have the latter company produce additional supplies of the recently approved J&J vaccines. The Post reports that the President will use the Defense Production Act to give Merck priority in purchasing equipment to ramp up for production.
This is a members-only article
Small Team. Big Results.
We’re proud of what our small newsroom has accomplished and it’s not hyperbole when we say that without our members, none of this would be possible.
Free memberships available for students and those experiencing financial hardship.
Already a member? SIGN IN